ADMA Biologics Announces First Commercial Sales of ASCENIV™
see the press release
ADMA Biologics is a biopharmaceutical company relentlessly committed to creating superior products for immunodeficient patients at risk for infection. It is our devotion to this underserved population that fuels us, and our hands-on approach to production and development that sets us apart.
ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference
ADMA Biologics to Present at Jefferies 2019 London Healthcare Conference:READ MOREADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress:READ MOREADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association
ADMA Biologics Announces Acceptance to the Plasma Protein Therapeutics Association:READ MORE